[关键词]
[摘要]
目的:分析羊膜移植(AMT)联合自体角膜缘干细胞移植(ALSCT)治疗眼表化学性烧伤(OSCB)的临床疗效及预后。
方法:回顾性分析2024年1月至2025年3月本院收治的OSCB患者资料,纳入患者分为两组,对照组采用ALSCT治疗,研究组采用AMT联合ALSCT治疗。使用1∶1最邻近匹配法进行倾向性匹配,比较两组OSCB患者的角膜上皮完全愈合时间、眼表修复率、实验室指标、并发症、预后指标。
结果:最终纳入对照组28例,男16例,女12例,平均年龄42.36±8.52岁; 研究组28例,男18例,女10例,平均年龄41.50±8.37岁; 研究组角膜上皮愈合时间早于对照组(P<0.05),眼表修复率、最佳矫正视力(LogMAR视力)优于对照组(均P<0.05),各并发症发生率、致盲率和对照组相近(均P>0.05),角膜缘干细胞缺乏评分分布情况研究组优于对照组(P<0.05)。术后2 wk,两组的血管内皮生长因子(VEGF)、转化生长因子-β1(TGF-β1)高于术前(均P<0.05),且研究组低于对照组(均P<0.05)。
结论:AMT联合ALSCT治疗OSCB,可促进角膜上皮完全愈合、眼表修复,调节VEGF、TGF-β1,改善视力,减轻角膜缘干细胞缺损程度,且未增加并发症、致盲率。
[Key word]
[Abstract]
AIM: To analyze the clinical efficacy and prognosis of amniotic membrane transplantation(AMT)combined with autologous limbal stem cell transplantation(ALSCT)in treating ocular surface chemical burn(OSCB).
METHODS: A retrospective analysis was conducted on the data of OSCB patients admitted to our hospital from January 2024 to March 2025. Patients were divided into two groups. The control group received ALSCT, while the study group received AMT combined with ALSCT. Propensity score matching was performed using 1∶1 nearest-neighbor matching method. The complete healing time of corneal epithelium, ocular surface repair rate, laboratory indicators, complications and prognostic indicators were compared between the two groups.
RESULTS: Finally, 28 participants(16 males and 12 females)were included in the control group, with an average age of 42.36±8.52 y.Totally 28 participants(18 males and 10 females)were in the study group, with an average age of 41.50±8.37 y. The healing time of corneal epithelium in the study group was earlier than that in the control group(P<0.05). The ocular surface repair rate and best corrected visual acuity(LogMAR)were better than those in the control group(all P<0.05). The incidence of various complications and blindness rate were comparable between the two groups(all P>0.05), and the distribution of corneal limbal stem cell deficiency score in study group was better than the control group(P<0.05). Two weeks after surgery, the levels of vascular endothelial growth factor(VEGF)and transforming growth factor-β 1(TGF-β1)in both groups were higher than those before surgery(all P<0.05), and the levels in the study group were lower than those in the control group(all P<0.05).
CONCLUSION: AMT combined with ALSCT for OSCB can promote complete corneal epithelial healing and ocular surface repair, modulate VEGF and TGF-β1, improve visual acuity, reduce the severity of limbal stem cell deficiency, without increasing complications or the blindness rate.
[中图分类号]
[基金项目]
邯郸市医学科学研究课题计划项目(No.20200422)